- |||||||||| Trial suspension: Multidrug Blister Pack Study (clinicaltrials.gov) - Apr 7, 2014
P=N/A, N=200, Suspended, Recruiting --> Withdrawn Recruiting --> Suspended
- |||||||||| Nucala (mepolizumab) / GSK
Enrollment open: Anti-IL-5 Therapy in Bullous Pemphigoid (BP) (clinicaltrials.gov) - May 1, 2013 P2, N=30, Recruiting, Initiation date: Nov 2012 --> Feb 2013 Not yet recruiting --> Recruiting
- |||||||||| Trial completion: Study of Alwextin (clinicaltrials.gov) - Nov 28, 2012
P2, N=8, Completed, N=34 --> 1 Active, not recruiting --> Completed
- |||||||||| Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
Enrollment open: Efficiency and Tolerance of Rituximab (mabth (clinicaltrials.gov) - Oct 8, 2012 P3, N=20, Recruiting, Active, not recruiting --> Completed Active, not recruiting --> Recruiting
|